AI assistant
Sending…
BioCardia, Inc. — Director's Dealing 2020
Jul 1, 2020
35081_dirs_2020-07-01_4c612e4f-3a49-4377-ab72-5ed251601444.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BioCardia, Inc. (BCDA;BCDAW)
CIK: 0000925741
Period of Report: 2020-06-30
Reporting Person: Duckers Eric (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-06-30 | Common Stock | F | 7154 | $2.40 | Disposed | 20523 | Direct |
Footnotes
F1: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on June 30, 2020 and does not represent a sale by the Reporting Person.
More from BioCardia, Inc.
Regulatory Filings
2026
Jun 5
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 21
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 20
Delisting Announcement
2026
Apr 15
Regulatory Filings
2026
Apr 2